Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields

Forgot Your Password?


Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:122

Pharmaceuticals Market Research

Items 1 to 10 of 1010 total
Show: 10 20 30 40
Sort by Position Date of Report
Set Ascending Direction
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

  1. Cephalon To Acquire Gemin X Pharmaceuticals - Deal Analysis from GlobalData

    Cephalon To Acquire Gemin X Pharmaceuticals - Deal Analysis from GlobalData

    Date of report : Dec 4, 2011
    $500.00

    Cephalon To Acquire Gemin X Pharmaceuticals - Deal Analysis from GlobalData Summary In March 2011, Cephalon announced that it had signed an agreement to acquire the outstanding stock of Gemin X Pharmaceuticals, Inc., for $225m cash on a cash-free, debt-free basis. Gemin X stockholders could also r...  Learn More

  2. FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade

    FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade

    Date of report : Dec 4, 2011
    $500.00

    FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade Summary GlobalData’s report, “FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade” provides key update on the approval of Yervoy as the first targeted therapy for melanoma. Sc...  Learn More

  3. Diabetic Foot Ulcer (DFU) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

    Diabetic Foot Ulcer (DFU) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

    Date of report : Dec 4, 2011
    $2,000.00

    Diabetic Foot Ulcer (DFU) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, “Diabetic Foot Ulcer (DFU) Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential s...  Learn More

  4. Uveitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

    Uveitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

    Date of report : Dec 4, 2011
    $2,000.00

    Uveitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, “Uveitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on...  Learn More

  5. Traumatic Brain Injury (TBI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

    Traumatic Brain Injury (TBI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

    Date of report : Dec 4, 2011
    $2,000.00

    Traumatic Brain Injury (TBI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, “Traumatic Brain Injury (TBI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essen...  Learn More

  6. Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals, April 2011

    Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals, April 2011

    Date of report : Dec 4, 2011
    $1,000.00

    Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals, April 2011 Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals, April 2011” report is an essential source of data and trend analysis on partnerships, licensing, ...  Learn More

  7. Cephalon To Acquire Gemin X Pharmaceuticals - Deal Analysis from GlobalData

    Cephalon To Acquire Gemin X Pharmaceuticals - Deal Analysis from GlobalData

    Date of report : Dec 4, 2011
    $500.00

    Cephalon To Acquire Gemin X Pharmaceuticals - Deal Analysis from GlobalData Summary In March 2011, Cephalon announced that it had signed an agreement to acquire the outstanding stock of Gemin X Pharmaceuticals, Inc., for $225m cash on a cash-free, debt-free basis. Gemin X stockholders could also r...  Learn More

  8. FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade

    FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade

    Date of report : Dec 4, 2011
    $500.00

    FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade Summary GlobalData’s report, “FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade” provides key update on the approval of Yervoy as the first targeted therapy for melanoma. Sc...  Learn More

  9. Diabetic Foot Ulcer (DFU) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

    Diabetic Foot Ulcer (DFU) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

    Date of report : Dec 4, 2011
    $2,000.00

    Diabetic Foot Ulcer (DFU) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, “Diabetic Foot Ulcer (DFU) Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential s...  Learn More

  10. Uveitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

    Uveitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

    Date of report : Dec 4, 2011
    $2,000.00

    Uveitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, “Uveitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on...  Learn More
Items 1 to 10 of 1010 total
Show: 10 20 30 40
Sort by Position Date of Report
Set Ascending Direction
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
Filter by

Filter Options

Category
  1. Biotechnology (235)
  2. OTC Pharmaceuticals (223)
  3. Ophthalmics (5)
Global Report
  1. (24)
  2. (218)
Report Type
  1. (1)
  2. (57)
  3. (90)
  4. (71)
Asia Pacific
  1. (10)
  2. (47)
  3. (12)
  4. (2)
  5. (20)
  6. (4)
  7. (4)
  8. (2)
  9. (2)
  10. (4)
  11. (5)
  12. (3)
  13. (6)
  14. (2)
  15. (5)
Africa
  1. (5)
  2. (3)
  3. (2)
  4. (11)
North America
  1. (11)
  2. (11)
  3. (15)
Eastern Europe
  1. (2)
  2. (1)
  3. (5)
  4. (9)
  5. (3)
  6. (18)
  7. (8)
  8. (2)
  9. (2)
  10. (3)
  11. (7)
South America
  1. (5)
  2. (18)
  3. (4)
  4. (3)
  5. (2)
  6. (2)
  7. (3)
Western Europe
  1. (3)
  2. (6)
  3. (7)
  4. (2)
  5. (8)
  6. (10)
  7. (5)
  8. (4)
  9. (8)
  10. (7)
  11. (7)
  12. (4)
  13. (8)
  14. (8)
  15. (4)
  16. (9)
Middle East
  1. (2)
  2. (1)
  3. (3)
  4. (4)
  5. (2)
Access Free Business Library
Compare Reports

You have no items to compare.

© 2012 Marketsensus Ltd. All Rights Reserved.

Marketsensus Ltd. | 545 Eighth Ave, Suite 401 Manhattan, NY 10018 | (212) 201-1308

LiveZilla Live Help